Supplementary Figure Legends from The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non–Small Cell Lung Cancer Growth
Edward B. Garon(University of California, Los Angeles), Dennis J. Slamon(University of California, Los Angeles), Amrita Desai(Oregon Health & Science University), Wylie Hosmer(Hartford Hospital), Emin Avşar(Novartis (Switzerland)), Cornelia Quadt(Novartis (Switzerland)), Habib Hamidi(Unknown), Judy Dering(Novartis (Switzerland)), Richard S. Finn(University of California, Los Angeles), Manway Liu, Michael Rugaard Jensen(Novartis (Switzerland)), Sharon Pitts(University of Maryland, College Park), Naeimeh Kamranpour(Novartis (Switzerland)), Steven M. Dubinett(University of California, Los Angeles), Susan Ide(Novartis (United States))
Cited by 0
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k